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Abstract
Background: The two most relevant pathologies of long-term peritoneal dialysis (PD) are simple sclerosis and encapsulating
peritoneal sclerosis (EPS). The histological differentiation of those two entities is difficult. The Aim of the study was to
establish a method to standardize and facilitate the differentiation between simple sclerosis and EPS
Methods: We investigated 58 peritoneal biopsies - 31 EPS patients and 27 PD patients. Two blinded investigators analyzed
20 histological characteristics in EPS and PD patients.
Results: The following findings were significantly more common in EPS than in patients on PD without EPS: fibroblast like
cells (FLC) (p,0.0001), mesothelial denudation (p,0.0001), decreased cellularity (p = 0.008), fibrin deposits (p,0.03), Fe
deposits (p = 0.05), podoplanin vascular (p,0.0001), podoplanin avascular (p,0.0001). Using all predictor variables we
trained the classification method Random Forest to categorize future cases. Podoplanin vascular and avascular were taken
together (p,0.0001), FLC (p,0.0001), mesothelial denudation (p = 0.0005), calcification (p = 0.0026), acellular areas
(p = 0.0094), and fibrin deposits (p = 0.0336) showed up as significantly important predictor variables. Estimated
misclassification error rate when classifying new cases turned out to be 14%.
Conclusion: The introduced statistical method allows discriminating between simple sclerosis and EPS. The misclassification
error will likely improve with every new case added to the database.
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Introduction
Encapsulating peritoneal sclerosis (EPS) is a rare but
devastating complication of peritoneal dialysis (PD). Although
several medical and surgical treatment approaches exist,
morbidity and mortality are still high [1–3]. Clinical symptoms,
radiologic findings, and histological criteria are the three
diagnostic pillars of EPS [4].
If clinical signs of bowel obstruction, abdominal pain or weight
loss occur, the disease is probably in an advanced stage. Earlier
signs, including changes in transporter status or ultrafiltration
failure, are common but not specific for the disease [5–9].
Even though abdominal computed tomography (CT) scanning
is an established diagnostic tool in EPS and the existing imaging
criteria are well defined, CT scanning alone does not allow one to
make the diagnosis of EPS. All the described imaging features
were also found in patients on PD without clinical signs of EPS
[10–13].
The two most relevant pathologies of long-term PD are simple
sclerosis and EPS. PD-induced simple fibrosis of the peritoneal
membrane is a very common finding in PD-patients as previously
described in the literature [14,15]. Compared to PD patients,
histological findings in EPS are described but not specific for the
disease [16]. Some authors state, that EPS is always a result of long
term PD, dependent on the duration of PD treatment. Others
state, that for the development of EPS a so called second hit is
mandatory and that PD duration itself does not cause EPS.
Discussed second hits are a severe peritonitis, an increased
peritonitis rate, several PD fluids or cessation of PD treatment
[17,18]. For a histological diagnosis of EPS, it is mandatory to
define reproducible histological criteria that can be used to
differentiate the two entities [6].
There are several publications about biopsy techniques, tissue
preparation and histological findings of the peritoneum [14,18–
21]. For immunohistochemistry, the method of cutting the paraffin
embedded tissue is not of great importance. But for morphological
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assessment, including the thickness of the submesothelial cell layer
or the extent of fibrosis, it is essential that histology techniques are
standardized. On the other hand, it is important to keep
techniques simple. Therefore, cutting the tissue perpendicular to
the surface could be feasible. Due to technical reasons (small
operational access) a trauma-free removal of peritoneum is often
impossible and obtained tissue samples are sometimes to small for
pinning onto cork boards.
In 2003 and 2005 Honda and colleagues published a paper with
12 EPS patients, which showed that fibrin deposition, fibroblast
swelling, capillary angiogenesis and mononuclear cell infiltration
were significantly more common in EPS than in peritonitis,
ultrafiltration failure, uremia and so called ‘‘pre-EPS’’. Regarding
the degree of these parameters, only fibroblast swelling and fibrin
deposition exhibited statistically significant differences [20].
Several markers for fibroblast proliferation were also investigated.
Garosi and colleagues investigated 224 peritoneal biopsies of
non-EPS patients and compared the morphological findings with
the biopsies of 39 patients with EPS. Significant findings in
patients with EPS were thickening of the submesothelial cell layer,
vasculopathy, inflammation, arterial occlusion, tissue calcification
and ossification and arterial calcification and ossification [22].
In 2008 Sherif and colleagues compared 12 EPS patients with
23 non-EPS patients. Only fibrin deposition and the thickness of
the compacta were significantly different [21].
The problem associated with most of the published data is that
data acquisition was not standardized, observers were not blinded
to the diagnosis, intra- and inter-observer variability was not given.
Up to now there is no established method to differentiate between
EPS and simple sclerosis.
The first aim of our study was to define relevant and
reproducible histological parameters in combination with an
immunohistochemical parameter in patients with EPS compared
to patients on PD without EPS [16]. Secondly, we tried to establish
a statistical method to standardize and facilitate the differentiation
of simple sclerosis and EPS for new cases.
Materials and Methods
Biopsies from the peritoneum were formalin-fixed in 4%
buffered formalin and paraffin-embedded following routine
protocols [23]. Included were biopsies from 27 patients on PD
without signs of EPS and 31 patients with clinical and radiological
diagnostic criteria for EPS [5,12]. Biopsies were taken from
patients on PD at the time of catheter removal, correction of
a catheter malposition or during abdominal surgery (e.g. hernia
repair, cholecystectomy). Patients with an episode of peritonitis
within the last 6 months were excluded. The biopsies from patients
with EPS were taken at the time of peritonectomy. Clinically, all
patients were in a late stage of the disease with recurrent
abdominal pain caused by chronic bowel obstruction.
All patients had given their informed consent regarding
a scientific work-up of tissues taken during routine procedures.
Immunohistochemistry was performed as previously described
[24,25]. Dewaxed and rehydrated tissue sections were incubated
in Peroxidase Blocking Solution (S 2023, DAKO, Hamburg,
Germany) (to block endogenous peroxidases). Pretreatment was
performed in a steamer, using an antigen retrieval solution (pH 9,
S 2367, DAKO). For immunostaining we used a Techmate system
(TechMate 500 Plus, DAKO). The staining method used a dex-
tran-coated peroxidase coupled polymer system (Dako REALTM
EnVisionTM Detektion Kit, Peroxidase/DAB+, Rabbit/Mouse, K
5007, DAKO).
A monoclonal mouse antihuman podoplanin antibody (D2–40,
DAKO, M 3619) was used on all biopsies, diluted 1:100 in
a commercial buffer system (antibody diluent, DAKO, S 2022)
[16]. As positive control, we used tissue with lymphatic vessels. A
negative control specimen was created by omitting the primary
antibody. Podoplanin was evaluated as either vascular or
podoplanin avascular (0,1,2,3).
From each slide hematoxylin and eosin staining was done for
morphological analysis: fibrosis: absent, 1–10%/low-power field
(LPF), 11–50%/LPF, .51%/LPF (0,1,2,3); a additional quanti-
tative consensus evaluation of the degree of fibrosis was done.
Tissue sections were scanned, visualized and the thickness of the
fibrosis zone was measured using the software program Image
Manager, version 4.0, Leica, Germany. FLC: absent, 1/5 high-
power fields (HPFs), 2–4/5 HPFs, .5/5 HPFs (0,1,2,3); exuda-
tion: absent, 1 small area in 1 MPF, 1 area ,50%/MPF, 1 area
.50%/medium-power field (MPF) (0,1,2,3); cellularity was
evaluated as 0 (1–2 nuclei/HPF), 1 (3–5 nuclei/HPF) 2 (6–20
nuclei/HPF) and 3 (.20 nuclei/HPF); variability of cellularity:
absent or present (0,1); vessel density: absent, 1–5/HPF, 6–10/
HPF, .10/HPF in the submesothelial cell layer and variability of
vessel density as absent or present (0,1); acute inflammation
(neutrophiles): absent, 1/HPF, 2–5/HPF, .5/HPF (0,1,2,3);
chronic inflammation (round cells): absent, 1–5/HPF, 6–20/
HPF, .20/HPF (0,1,2,3); hemorrhage: absent extravasal erythro-
cytes, 1 area ,10%/5 LPF, 2+3 area/5 LPF or 1 area 11–30%/
LPF, 4+5 area/5 LPF or 1 area .30%/LPF (0,1,2,3); mesothelial
hyperplasia: more than 2 layers of mesothelial cells (0,1); fibrin
deposits: absent eosinophilic area, 1 area ,5%/5 MPF, 1 area 6–
20%/5 MPF, 1 area .20%/5 MPF (0,1,2,3); presence of
vasculopathy: thickening of vessel walls and/or inflammation of
the vessel wall (0,1); mesothelial denudation: no visible mesothe-
lium (0,1); presence of acellular areas (0,1); presence of brown,
probably iron deposits (0,1); presence of blue, probably calcium
deposits (0,1), and osseous metaplasia (0,1). FLC were defined as
elongated cells, separated from vessel lumen with vesicular nucleus
and one to three nucleoli. Acute inflammatory reaction was
defined by the presence of neutrophilic granulocytes. Chronic
inflammatory reaction was defined by the presence of round cells
without taking into consideration further subclasses such as
lymphocytes, plasma cells, monocytes and histiocytes.
HPF=0.26 mm2, MPF=0.91 mm2, LPF=3.2 mm2. Two
experienced observers (one pathologist and one nephrologist)
blinded to the specimen’s diagnosis evaluated each section in two
independent rounds.
The intra-observer variability of 20 histological variables was
studied in a two level classification and a four level classification by
two observers blinded to diagnosis. The intra-observer variability
of a two level classification versus a four level classification system
showed better kappa values. A four level classification was not
suitable for all investigated variables because some findings were
only classified as absent or present. Using a two level classification,
the mean kappa value of the intra-observer variability increased
form 0.5560.12 to 0.7060.07 (p= 0.002). The intra- and inter-
observer variability is given in Table 1. For most morphological
findings, the intra- and inter-observer variability was moderate
(kappa value .0.4) or good (kappa values .0.6). Parameters with
kappa values ,0.4 were either not considered for further
evaluation or a consensus evaluation was done.
Statistical Analysis
Two observers blinded to the diagnosis performed the semi
quantitative scoring. Variables were classified as either binary
(present or absent) or ordinal. The ordinal variables were
Histological Criteria for EPS
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discriminated as absent, low grade, moderate grade and high
grade. We compared a four level classification system with a two
level classification system. Each parameter was analyzed for its
intra-observer and inter-observer variability. All data were
processed using the software program S-Plus (version 6.1).
Comparisons between different disease groups were made using
analysis of variances (ANOVA) and the Fisher-test. Statistical
results with a p-value p,0.05 are considered as significant, such
with p,0.01 as highly significant, and such with p,0.001 as very
highly significant. To predict EPS on the basis of a given set of
predictor variables we used Random Forest version 4.6-2 (R
Development core, version 2.11.0) [26], a classification method
which is well known for its accuracy in classifying new cases [27].
Due to the phenomenon of separation, plain logistic regression
can’t be applied.
Results
Biopsies from the peritoneum of 27 patients on PD without signs
of EPS were compared to 31 patients with clinical and radiological
diagnostic criteria for EPS (Table 2). Clinical data were available
in 29 of 31 EPS patients. All EPS patients underwent major
surgery with with peritonectomy and enterolysis (PEEL) due to
bowel obstruction. All patients in the EPS group had symptoms
consistent with EPS. Abdominal pain or vomiting were reported
by all patients in the EPS group. Additionally, a large proportion
had both symptoms. Weight loss was noted in almost all patients in
this group.
CT scanning was performed in 19 out of 31 patients. Most
common CT findings reported to support the diagnosis of EPS
were peritoneal thickening (12 of 19 patients), small bowel
dilatation caused by bowel obstruction was reported in 8 of 19
patients. Other findings were calcification and ascites. Up to know,
24 of 29 EPS patients were alive (mean follow up 62.1637.0
Table 1. Intra- and inter-observer variability of 20 histological variables (two level classification).
Variable
Intra- observer variability
Mean kappa
Inter- observer variability
Mean kappa
Fibrosis 0.56 0.51
FLC 0.63 0.12
Exudation 0.72 0.75
Mesothelial denudation 0.75 0.73
Acellular areas 0.69 0.60
Cellularity 0.63 0.68
Cellularity- variability 0.54 0.29
Vessel density 0.63 0.47
Vessel density- variability 0.40 0.26
Acute inflammation 0.82 0.41
Chronic inflammation 0.67 0.57
Vasculopathy 0.48 0.23
Hemorrhage 0.79 0.47
Fibrin deposits 0.75 0.93
Calcification 1 0
Iron deposits 0.79 0.11
Ossification No event No event
Mesothelial hyperplasia No event No event
Podoplanin vascular 0.87 0.72
Podoplanin avascular 0.88 0.12
doi:10.1371/journal.pone.0048647.t001
Table 2. Imaging and clinical features of EPS patients.
Imaging features
Peritoneal enhancement 15/25
Peritoneal thickening 23/25
Peritoneal calcifications 4/25
Large bowel wall thickening 6/25
Small bowel wall thickening 11/25
Adhesions of bowel loops 16/25
Signs of bowel obstruction 12/25
Fluid loculation/septation 17/25
Clinical features
Bowel obstruction
Nausea and vomiting 29/29
Loss of appetite 29/29
Loss of weight 24/29
Abdominal pain 29/29
Diarrhea 11/29
Inflammation
Fever 8/29
Ascites 20/29
doi:10.1371/journal.pone.0048647.t002
Histological Criteria for EPS
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months). The clinical data from the patient cohort is summarized
in Table 3.
Compared to the PD-group, there were significant more male
than female in the EPS-group. Time on PD was longer and
peritonitis rate was higher in EPS patients. As expected, there was
a significant difference regarding transporter status and use of
icodextrin between the two groups. None of the PD-patients
without EPS had ultrafiltration failure, whereas 8 out of 31
patients in the EPS group developed ultrafiltration failure.
Smokers and patients suffering from hypertension were more
common in EPS. Leucocytes were higher and urea-N was lower
compared to patients in the PD-group.
The following findings were significantly more common in EPS
than in PD-patients without EPS (Table 4): fibroblast-like cells
(FLC) (p,0.0001), mesothelial denudation (p,0.0001), decreased
cellularity (p = 0.008), fibrin deposits (p,0.03), positive iron
staining (p = 0.05) and immunohistochemistry for podoplanin
vascular (p,0.0001) and podoplanin avascular (p,0.0001)
(Figure 1 and 2). A first semi quantitative approach, regarding
the degree of fibrosis showed no significant difference. A second
quantitative consensus analysis with optimized tissue engineering
showed a significant difference between EPS and PD: 602,9 mm
vs. 1132,5 mm; p= 0.0031 (Figure 3). Due to the methodological
effort and the need for consensus analysis to increase the
reproducibility, we excluded fibrosis from further analysis.
Using all predictor variables as given in Table 4 we trained the
classification method Random Forest to categorize future cases
(Table 5). Podoplanin vascular and avascular were taken together
(p,0.0001), FLC (p,0.0001), mesothelial denudation
(p = 0.0005), calcification (p = 0.0026), acellular areas
(p = 0.0094), fibrin deposits (p = 0.0336) showed up as significantly
important predictor variables. Estimated misclassification error
rate when classifying new cases turned out to be 14%.
Discussion
There are significant morphological differences between peri-
toneal biopsies of PD-patients compared to PD-patients with EPS.
Our study is the first standardized approach to define histological
criteria in the diagnosis of EPS.
We investigated histological parameters introduced in previous
studies and combined them with further promising parameters
[20–22]. To keep these results reproducible in daily practice, we
calculated the intra- and inter-observer variability (two- and four-
level) and excluded kappa values below 0.4. To keep histological
work-up simple, we used HE-staining and one single immunohis-
tochemical staining (podoplanin). Podoplanin was found to be
a good marker for lymphatic endothelial cells, but it is also
expressed by peritoneal mesothelial cells [28]. As podoplanin can
bind chemokines, it may modulate the inflammatory milieu, and
therefore might be involved in the injury process of both simple
sclerosis and EPS [29]. A previous study of our research group
demonstrated that podoplanin might be a suitable marker to
discriminate between simple sclerosis and EPS [16].
The chosen statistical method in this study is Random Forest.
Due to empty cells in cross tabulation and co-linearity of variables
plain multiple logistic regression can’t be applied. Random Forest
is a classification system, which consists of many different decision
trees. Each tree gives a classification and votes for a class. The
forest chooses the classification having the most votes. Using
Random Forest it is possible to calculate the importance of each
histological parameter. Therefore, it is the optimal statistical
method for a web-based database. Even small centers with only
few EPS cases will have the opportunity to benchmark their
histological findings and to calculate the misclassification error.
The method allows to calculate the probability of a new case to be
either EPS or simple sclerosis. For example a case with fibrosis (1),
FLC (1), exudation (0), increased vessel density (0), increased
cellularity (0), acute inflammation (1), chronic inflammation (0),
heamorrhage (0), fibrin deposits (0), Fe deposits (0), calcification
(1), mesothelial denudation (1), acellular areas (1), vasculopathy (0)
and podoplanin staining (1) has a EPS probability of 0.96. We
Table 3. Clinical data of study patients.
Variable PD – no EPS EPS
n 27 31
Age 50.6 46.4
(years;mean 6SD) 613.6 612.8
Female/Male** 13/14 7/24
PD-duration in 37.6 77.5
months*** 638.0 641.2
Peritonitis** 20 in 1014 months 55 in 2170 months
1:50.7 1:39.5
Transporter status**
High/high average 4 11
Low/low average 8 3
N.D. last 6 months 15 17
Composition of PDF
Neutral pH 5/27 9/31
Acidic pH 8/27 12/31
Both or N.D. 14/27 10/31
Icodextrin** 2/14 17/21
13 N.D. 10 N.D.
Diabetes 8/27 7/31
Smoker*** 4/24 10/19
3 N.D. 12 N.D.
Hypertension*** 19/27 26/31
Hb 11.2 10.4
(g/dl 6 SD [13–18]) 61.7 63.4
Leukocytes** 7.6 9.5
(G/L 6 SD [4.0–11.3]) 62.0 63.8
Phosphate 1.8 1.6
(mmol/l [0.68–1.68]) 60.6 60.6
Calcium 2.4 2.3
(mmol/l [1.90–2.70]) 60.2 60.4
PTH 17.9 20.5
(pmol/l [1.1–7.3]) 617.1 622.5
Urea-N** 58.2 39.6
(mg/dl [10–25]) 631.5 618.2
Creatinine 8.1 7.3
(mg/dl [0.5–1.4]) 63.2 62.4
PD, peritoneal dialysis; EPS, encapsulating peritoneal sclerosis; PDF, peritoneal
dialysis fluid; Hb, haemoglobin; N.D., not determined; PTH, parathyroid
hormone,
***p,0.001.
**p,0.05.
*p,0.1.
doi:10.1371/journal.pone.0048647.t003
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Figure 1. Histopathological findings in EPS compared to simple sclerosis. A HE staining showing an increased cellularity, round cells and
fibroblast like cells (arrows). EPS, original magnification6400; B HE staining showing a decreased cellularity, fibrin deposits and a complete
denudation of the mesothelial cell layer with fibrin exudations (arrows). EPS, original magnification6100; C HE staining showing a decreased
cellularity with intracellular matrix (arrows), complete mesothelial denudation with fibrin exudations. EPS, original magnification6200; D HE staining
showing an increased cellularity, hemorrhage, round cells, fibroblast like cells and fibrin deposits (arrows). EPS, original magnification6400; E Fe
staining showing vessels, intraluminal erythrocytes and Fe deposits (arrows). EPS, original magnification6400; F D2–40 stained section showing
podoplanin positive cells associated to vessels (arrows). EPS, original magnification6400.
doi:10.1371/journal.pone.0048647.g001
Histological Criteria for EPS
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expect that the misclassification error of 14% in our study will
improve with every new case added to the database.
Mesothelial denudation, calcifications and acute and chronic
inflammation were previously described [18,20,22]. Fibrin depos-
its, previously reported as a landmark of EPS, were found in 6 out
of 31 EPS cases but in none of the PD-group. The fibrin
deposition could be linked to decreased fibrin clearance by
peritoneal mast cells [30].
Decreased cellularity, with an increased amount of intracellular
matrix, is a new finding. An explanation for this finding in our
cohort could be the late stage of the disease [30].
FLCs are indicative for EPS. Previous studies identified this cell
type as fibroblasts, activated fibroblasts or myofibroblasts [16,31].
Without using immunohistochemistry, further differentiation of
this cell type is not possible. To keep analysis simple, all cells with
this fibroblast-appearance were characterized as fibroblast-like
cells (FLC).
Angiogenesis, often described as a typical finding in EPS, is
difficult to reproduce, because the variability of the number of
vessels in the same slide is high and most of the detected vessels are
probably lymphatic vessels [15,16,20].
Figure 2. Histopathological findings in EPS compared to simple sclerosis. A D2–40 stained section showing podoplanin positive cells not
associated to vessels (arrows). EPS, original magnification6400; B HE staining showing acute and chronic inflammation with round cells and
neutrophils (arrows). EPS, original magnification6400; C HE staining showing fibroblast like cells, eosinophils, plasma cells and round cells (arrows).
EPS, original magnification6400; D HE staining showing vasculitis, round cells and calcium deposits (arrows). EPS, original magnification6100.
doi:10.1371/journal.pone.0048647.g002
Figure 3. Thickness of the fibrosis zone in the submesothelial
cell layer in PD patients and patients on PD with EPS. p=0.031;
range PD group 227–2581 mm; range EPS group 281–2150 mm.
doi:10.1371/journal.pone.0048647.g003
Histological Criteria for EPS
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In our study we performed a semi quantitative analysis of the
extend of fibrosis and found no significant difference between EPS
and PD. A second, quantitative consensus approach followed by
optimized tissue engineering showed a significant result. Re-
markably, the range of fibrosis was very much the same in the two
groups and underlines the problem of a reliable analysis. Due to
the complex methodology and the low reproducibility, fibrosis was
excluded from further analysis. Previous studies regarding
histological parameters in EPS and PD measured the subme-
sothelial cell layer, the compact zone, the degenerated layer
thickness and the thickness of sclerosis. Details about tissue
engineering were not given and definitions and details regarding
the measured variables are unclear [21,22]. Further multicenter
approaches with a consensus regarding these variables are needed.
In our cohort, calcifications were rare and ossifications were
absent. If calcification was present, it was highly indicative for
EPS.
Several of the analyzed parameters occur primarily in EPS and
are uncommon in PD-patients. Few EPS patients exhibit these
morphological changes, which lead us to conclude that a combi-
nation of histological criteria is necessary to increase specificity and
sensitivity.
The combination of clinical criteria [7,32,33], radiological
scores [6,11,13] and standardized histological criteria, will enable
nephrologists and pathologists to further increase sensitivity and
specificity in the diagnosis of EPS. Recently implemented
minimally invasive procedures are setting the stage to facilitate
tissue retrieval with minimal damage to the peritoneal membrane
[34,35].
Our study is a first standardized approach towards histological
criteria for EPS. Several limitations of the study have to be
addressed. Our institution is a referral center for PD patients.
Therefore, in patients referred from other centers, measurement of
membrane function is not standardized. Recent membrane
function tests are sometimes not available in all patients at the
time of diagnosis. Additionally, due to the difference in time on PD
between the two groups it is possible that some of the histological
features in the EPS group could reflect non-specific membrane
damage from PD rather than EPS itself.
In conclusion, we introduced standardized histological criteria
for EPS and a statistical method, which facilitates to discriminate
between simple sclerosis and EPS. To confirm these findings,
further studies in unrelated cohorts will examine histological
specimens of additional EPS patients.
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Podoplanin avascular 7/27 23/31 ,0.0001
doi:10.1371/journal.pone.0048647.t004
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Vasculopathy 1.5955 0.0553
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doi:10.1371/journal.pone.0048647.t005
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